Cardiovascular complications in diabetes mellitus

Current Opinion in Pharmacology

Volumn 5, Issue 2 SPEC. ISS., 2005, Pages 143-148

  Sobel, Burton E ^a   Schneider, David J ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADVANCED GLYCATION END PRODUCT; ALDOSTERONE; ALLOXAN; AMINOGUANIDINE; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INSULIN; METFORMIN; STREPTOZOCIN;

ALLOXAN DIABETES MELLITUS; ARTERY COMPLIANCE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL RUPTURE; BODY WEIGHT DISORDER; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG TARGETING; HEART VENTRICLE COMPLIANCE; HUMAN; MICROANGIOPATHY; MORBIDITY; MORTALITY; NONHUMAN; PERIPHERAL EDEMA; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; SYSTEMATIC REVIEW;

EID: 15044363056     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2005.01.002     Document Type: Review

References (51)

1. H.P. Himsworth Diabetes Mellitus: Its differentiation into insulin-sensitive and insulin insensitive types Lancet i 1936 127-130
2. B.E. Sobel D.J. Schneider Causal connections B.E. Sobel D.J. Schneider Medical Management of Diabetes and Heart Disease 2002 Marcel Dekker, Inc New York 1-8
3. J.A. Ambrose A.M. Tannenbaum D. Alexpoulos C.E. Hjemdahl-Monsen J. Leavy M. Weiss S. Borrico R. Gorling V. Fuster Angiographic progression of coronary artery disease and the development of myocardial infarction J Am Coll Cardiol 12 1988 56-62
4. W.C. Little M. Constantinescu R.J. Applegate M.A. Kutcher M.T. Burrows F.R. Kahl W.P. Santamore Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 78 1988 1157-1166
5. M.J. Davies P.D. Richardson N. Woolf D.R. Kratz J. Mann Risk of thrombosis in human atherosclerotic plaques role of extracellular lipid, macrophage, and smooth muscle content Br Heart J 69 1993 377-381
6. A.P. Burke F.D. Kolodgie A. Zieske D.R. Fowler D.K. Weber P.J. Varghese A. Farb R. Virmani Morphologic findings of coronary atherosclerotic plaques in diabetics: A postmortem study Arterioscler Thromb Vasc Biol 24 2004 1266-1271
7. D.W. Sommeijer A. Beganovic C.G. Schalkwijk H. Ploegmakers C.M. van der Loos B.E. van Aken H. ten Cate A.C. van der Wal More fibrosis and thrombotic complications but similar expression patterns of markers for coagulation and inflammation in symptomatic plaques from DM2 patients J Histochem Cytochem 52 2004 1141-1149
8. T. Almdal H. Scharling J.S. Jensen H. Vestergaard The independent effect of type 2 diabetes on ischemic heart disease, stroke and death: A population-based study of 13,000 men and women with 20 years of follow-up Arch Intern Med 164 2004 1422-1426
9. R.J. Stevens R.L. Coleman A.I. Adler I.M. Stratton D.R. Matthews R.R. Holman Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66 Diabetes Care 27 2004 201-207
10. J.M. Forbes L.T. Yee V. Thallas M. Lassila R. Candido K.A. Jandeleit-Dahm M.C. Thomas W.C. Burns E.K. Deemer S.M. Thorpe et al. Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis Diabetes 53 2004 1813-1818
11. G. Basta A.M. Schmidt R.D. De Caterina Advanced gylcation end products and vascular inflammation: Implications for accelerated atherosclerosis in diabetes Cardiovasc Res 63 2004 582-592
12. M. Rewers D. Zaccaro R. D'Agostino S. Haffner M.F. Saad J.V. Selby R. Bergman P. Savage Insulin sensitivity, insulinemia, and coronary artery disease: The Insulin Resistance Atherosclerosis Study Diabetes Care 27 2004 781-787
13. K.E. Kip O.C. Marroquin D.E. Kelley B.D. Johnson S.F. Kelsey L.J. Shaw W.J. Rogers S.E. Reis Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: A report from the Women's Ischemia Syndrome Evaluation (WISE) study Circulation 109 2004 706-713
14. B.E. Sobel D.J. Taatjes D.J. Schneider Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis Arterioscler Thromb Vasc Biol 23 2003 1979-1989
15. D.J. Schneider M. Hayes M. Wadsworth H. Taatjes M. Rincon D.J. Taatjes B.E. Sobel Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type 1 (PAI-1) J Histochem Cytochem 52 2004 1091-1099
16. M.B. Schulze E.B. Rimm T. Li N. Rifai M.J. Stampfer F.B. Hu C-reactive protein and incident cardiovascular events among men with diabetes Diabetes Care 27 2004 889-894
17. M. Schillinger M. Exner J. Amighi W. Mlekusch S. Sabeti H. Rumpold O. Wagner E. Minar Joint effects of C-reactive protein and glycated hemoglobin in predicting future cardiovascular events of patients with advanced atherosclerosis Circulation 108 2003 2323-2328
18. M.K. Rutter J.B. Meigs L.M. Sullivan R.B. D'Agostino Sr. P.W. Wilson C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study Circulation 110 2004 380-385
19. P.S. Mehler J.R. Coll R. Estacio A. Esler R.W. Schrier W.R. Hiatt Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes Circulation 107 2003 753-756
20. E. Janzon B. Hedblad G. Berglund G. Engstrom Tobacco and myocardial infarction in middle-aged women: A study of factors modifying the risk J Intern Med 256 2004 111-118
21. H.S. Lim A.D. Blann G.Y. Lip Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: Relationships to cardiovascular disease and risk factor intervention Circulation 109 2004 2524-2528
22. F.K. Keating D.A. Whitaker S.S. Kabbani M.A. Ricci B.E. Sobel D.J. Schneider Relation of augmented platelet reactivity to the magnitude of distribution of atherosclerosis Am J Cardiol 94 2004 725-728
23. K. Iwakura H. Ito M. Ikushima S. Kawano A. Okamura K. Asano T. Kuroda K. Tanaka T. Masuyama M. Hori K. Fujii Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction J Am Coll Cardiol 41 2003 1-7
24. F.K. Keating B.E. Sobel D.J. Schneider Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes mellitus Am J Cardiol 92 2003 1362-1365
25. A. Schafer N.J. Alp S. Cai C.A. Lygate S. Neubauer M. Eigenthaler J. Bauersachs K.M. Channon Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo Arterioscler Thromb Vasc Biol 24 2004 1720-1726
26. K. Kain A.J. Catto P.J. Grant Associations between insulin resistance and thrombotic risk factors in high-risk South Asian subjects Diabet Med 20 2003 651-655
27. W.C. Knowler E. Barrett-Connor S.E. Fowler R.F. Hamman J.M. Lachin E.A. Walker D.M. Nathan Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 2002 393-403
28. P. Gaede P. Vedel N. Larsen G.V. Jensen H.H. Parving O. Pedersen Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes N Engl J Med 348 2003 383-393
29. K. Franklin R.J. Goldberg F. Spencer W. Klein A. Budaj D. Brieger M. Marre P.G. Steg N. Gowda J.M. Gore Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events Arch Intern Med 164 2004 1457-1463
30. I. Gustafsson B. Brendorp M. Seibaek H. Burchardt P. Hildebrandt L. Kober C. Torp-Pedersen for the Danis Investigatord of Arrhythmia and Mortality Dofetilde Study Group Influence of diabetes and diabetes - gender interaction on the risk of death in patients hospitalized with congestive heart failure J Am Coll Cardiol 43 2004 771-777
31. R.M. Henry O. Kamp P.J. Kostense A.M. Spijkerman J.M. Dekker R. van Eijck G. Nijpels R.J. Heine L.M. Bouter C.D. Stehouwer Left ventricular mass increases with deteriorating glucose tolerance, especially in women: Independence of increased arterial stiffness or decreased flow-mediated dilation: The Hoorn Study Diabetes Care 27 2004 522-529
32. J.I. Barzilay R.A. Kronmal J.S. Gottdiener N.L. Smith G.L. Burke R. Tracy P.J. Savage M. Carlson The association of fasting glucose levels with congestive heart failure in diabetic adults >65 years J Am Coll Cardiol 43 2004 2236-2241
33. E.F. Lewis L.A. Moye J.L. Rouleau F.M. Sacks J.M.O. Arnold J.W. Warnica G.C. Flaker E. Braunwald M.A. Pfeffer Predictors of late development of heart failure in stable survivors of myocardial infarction. The CARE Study J Am Coll Cardiol 42 2003 1446-1453
34. J.R. Timmer J.P. Ottervanger K. Thomas J.C.A. Hoorntje M.-J. de Boer H. Suryapranata F. Zijlstra for the Zwolle Myocardial Infarction Study Group Long-term, cause-specific mortality after myocardial infarction in diabetes Eur Heart J 25 2004 926-931
35. K. Malmberg S. Yusuf H.C. Gerstein J. Brown F. Zhao D. Hunt L. Piegas J. Calvin M. Keltai A. Budaj Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry Circulation 102 2000 1014-1019
36. M. Klaphotz M. Mauer A.M. Lowe F. Messineo J.S. Meisner J. Mitchell J. Kalman R.A. Phillips R. Steingart E.J. Brown Jr. et al. for the New York Heart Failure Consortium Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction. Results of the New York Heart Failure Registry J Am Coll Cardiol 43 2004 1432-1438
37. J.L. Izzo Jr. Arterial stiffness and the systolic hypertension syndrome Curr Opin Cardiol 19 2004 341-352
38. A. Norhammar K. Malmberg E. Diderholm B. Lagerqvist B. Lindahl L. Ryden L. Wallentin Diabetes mellitus: The major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revasscularization J Am Coll Cardiol 43 2004 585-591
39. S.R. Wilson B.A. Vakili W. Sherman T.A. Sanborn D.L. Brown Effect of diabetes on long-term mortality following contemporary percutaneous coronary intervention Diabetes Care 27 2004 1137-1142
40. K. Malmberg Role of insulin - glucose infusion in outcomes after acute myocardial infarction: The diabetes and insulin - glucose infusion in acute myocardial infarction (DIGAMI) study Endocr Pract 10 Suppl 2 2004 13-16
41. M.N. Sack D.M. Uellopn Insulin therapy as an adjunct to reperfusion after acute coronary ischemia J Am Coll Cardiol 41 2003 1404-1407
42. H.L. Lazar S.R. Chipkin C.A. Fitzgerlad Y. Bao H. Cabral C.S. Asptein Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events Circulation 109 2004 1497-1502
43. G.R. Norton G. Candy A.J. Woodiwiss Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats Circulation 93 1996 1905-1912
44. D. Susic J. Varagic J. Ahn E.D. Frohlich Crosslink breakers: A new approach to cardiovascular therapy Curr Opin Cardiol 19 2004 336-340
45. V. Thohan G. Torre-Amione M.M. Koerner Aldosterone antagonism and congestive heart failure: A new look at an old therapy Curr Opin Cardiol 19 2004 301-308
46. K.T. Weber Y. Sun S.E. Campbell Structural remodelling of the heart by fibrous tissue: Role of circulating hormones and locally produced peptides Eur Heart J 16 Suppl N 1995 12-18
47. B. Pitt F. Zannad W.J. Remme R. Cody A. Castaigne A. Perez J. Palensky J. Wittes The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709-717
48. K. Takeshita M. Hayashi S. Iino T. Kondo Y. Inden M. Iwase T. Kojima M. Hirai M. Ito D.J. Loskutoff et al. Increased expression of plasminogen activator inhibitor-1 in cardiomyocytes contributes to cardiac fibrosis after myocardial infarction Am J Pathol 164 2004 449-456
49. A.K. Zaman S. Fujii H. Sawa D. Goto N. Ishimori K. Watano T. Kaneko T. Furumoto T. Sugawara I. Sakuma et al. Angiotensin-converting enzyme inhibition aattenuates hypofibrinolysis and reduces cardiac perivascular fibrosis in genetically obese diabetic mice Circulation 103 2001 3123-3128
50. T. Shiomi H. Tsutsui S. Hayashidani N. Suematsu M. Ikeuchi J. Wen M. Ishibashi T. Kubota K. Egashira A. Takeshita Pioglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction Circulation 106 2002 3126-3132
51. R.W. Nesto Thiazolidinedione use, fluid retention, and congestive heart failure: A consensus statement from the American Heart Assocation and American Diabetes Association: Response to Elasy and Griffin Diabetes Care 27 2004 2096